South Korea Sepsis Diagnostics Market Size & Outlook
South Korea sepsis diagnostics market, 2018-2030 (US$M)
Related Markets
South Korea sepsis diagnostics market highlights
- The South Korea sepsis diagnostics market generated a revenue of USD 19.7 million in 2022 and is expected to reach USD 46.1 million by 2030.
- The South Korea market is expected to grow at a CAGR of 11.2% from 2023 to 2030.
- In terms of segment, blood culture media was the largest revenue generating product in 2022.
- Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Sepsis diagnostics market data book summary
| Market revenue in 2022 | USD 19.7 million |
| Market revenue in 2030 | USD 46.1 million |
| Growth rate | 11.2% (CAGR from 2022 to 2030) |
| Largest segment | Blood culture media |
| Fastest growing segment | Assay Kits & Reagents |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
| Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Other key industry trends
- In terms of revenue, South Korea accounted for 2.0% of the global sepsis diagnostics market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 77.2 million by 2030.
Blood culture media was the largest segment with a revenue share of 39.09% in 2022. Horizon Databook has segmented the South Korea sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
The sepsis diagnostics market in South Korea is driven by technological advancements, government initiatives, rising sepsis incidence, and a robust healthcare infrastructure. According to a 2023 report by the Korean Society of Emergency Medicine, mortality rates from sepsis and septic shock in Korea remain significantly high.
Specifically, for septic shock, the in-hospital mortality rate is around 30%, highlighting the critical severity of this condition within the country’s healthcare system. The increasing geriatric population and limited awareness are making citizens more susceptible to sepsis.
These factors are collectively anticipated to propel market growth in the country. South Korea is at the forefront of integrating advanced technologies into its healthcare system. According to the report published by the Society of Critical Care Medicine.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sepsis Diagnostics Market Scope
Sepsis Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Korea sepsis diagnostics market size, by product, 2018-2030 (US$M)
South Korea Sepsis Diagnostics Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
